LOS ANGELES, Aug. 2, 2005 (PRIMEZONE) -- Cord Blood America, Inc. (OTCBB:CBAI), an umbilical cord blood stem cell preservation company, applauds the recent endorsement by Senator Bill Frist, M.D. on the Stem Cell Research Enhancement Act.
"Stem cells taken from cord blood have shown great promise"
Senator Frist's comments on Stem Cell Research came from the floor of the Senate on July 29, 2005. The following is taken from Senator Frist's statements: ". . . And stem cells taken from cord blood have shown great promise in treating leukemia, myeloproliferative disorders and congenital immune system disorders. Recently, cord blood cells have shown some ability to become neural cells, which could lead to treatments for Parkinson's disease and heart disease.
Thus, we should also strongly support increased funding for adult stem cell research. I'm a cosponsor of a bill that will make it much easier for patients to receive cord blood cell treatments."
To read Senator Bill Frist's full speech please follow this link:
http://www.agoracom.com/nonmemforum/msgreview.asp?id=415782&refid=0&orig=415782
Cord Blood America Chairman & CEO, Matthew L. Schissler stated, "Cord Blood America endorses the recent statement by Majority Leader Frist and believes this is a major step in the eventual passage of the Stem Cell Research Enhancement Act. Senator Frist's call to ease restrictions on Stem Cell Research, accompanied by the Senator's strong ethical guidelines will surely help passage of the Act in the Senate," added Mr. Schissler.
About Cord Blood America
Cord Blood America (OTCBB:CBAI) is the parent company of Cord Partners, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and life-saving resource for treating a growing number of ailments, including cancer, leukemia, or blood and immune disorders. For more information on how this precious lifeline can benefit your family, visit www.cordpartners.com.
Forward-Looking Statements
This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. Forward-looking statements include, without limitation, our ability to increase income streams, to grow revenue and earnings, and to obtain additional cord blood banking revenue streams. These statements are only predictions and are subject to certain risks, uncertainties and assumptions, which are identified and described in the Company's public filings with the Securities and Exchange Commission.